Provided by Tiger Trade Technology Pte. Ltd.

BriaCell Therapeutics Corp.

3.59
-0.4800-11.79%
Volume:8.33M
Turnover:30.60M
Market Cap:31.23M
PE:-0.37
High:4.04
Open:4.04
Low:3.45
Close:4.07
52wk High:14.68
52wk Low:2.60
Shares:8.70M
Float Shares:7.86M
Volume Ratio:88.22
T/O Rate:105.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.6592
EPS(LYR):-62.1862
ROE:-175.25%
ROA:-90.84%
PB:1.30
PE(LYR):-0.06

Loading ...

Aug 01, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 16, 2025

Major Issues Report

Form 8-K - Current report
Jul 15, 2025

Correspondence

Form CORRESP - Correspondence
Jul 15, 2025

Correspondence

Form CORRESP - Correspondence
Jul 15, 2025

Correspondence

Form CORRESP - Correspondence
Jul 15, 2025

Correspondence

Form CORRESP - Correspondence
Jul 12, 2025

Correspondence

Form CORRESP - Correspondence
Jul 12, 2025

Correspondence

Form CORRESP - Correspondence
Jul 11, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 10, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 09, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 09, 2025

Correspondence

Form CORRESP - Correspondence
Jul 09, 2025

Correspondence

Form CORRESP - Correspondence
Jul 08, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 08, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 16, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2025

Major Issues Report

Form 8-K - Current report
Apr 23, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 22, 2025

Correspondence

Form CORRESP - Correspondence